CELLDEX THERAPEUTICS INC
NASDAQ: CLDX (Celldex Therapeutics, Inc.)
Kemas kini terakhir: 12 jam lalu39.18
2.28 (6.18%)
| Penutupan Terdahulu | 36.90 |
| Jumlah Dagangan | 1,000,166 |
| Harga / Jualan (P/S) | 16.20 |
| Harga / Buku (P/B) | 4.06 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -9,027.19% |
| EPS Cair (TTM) | -2.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 345.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.49% |
| Nisbah Semasa (MRQ) | 21.67 |
| Aliran Tunai Operasi (OCF TTM) | -171.51 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -101.09 M |
| Pulangan Atas Aset (ROA TTM) | -16.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -23.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Celldex Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -2.50 |
|
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.32% |
| % Dimiliki oleh Institusi | 113.13% |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |